Showing 1,401 - 1,420 results of 101,024 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( 5 ((teer decrease) OR (mean decrease)) ))', query time: 1.41s Refine Results
  1. 1401
  2. 1402
  3. 1403

    Inhibition of SHP-2 activity decreases <i>C</i>. <i>parvum</i> infectivity. by Eunice A. Varughese (824701)

    Published 2015
    “…<p>A) Dose-dependent decrease of Infections per field of view (y-axis) after treatment of FHs 74 Int cells with increasing concentrations of the SHP-2-specific inhibitor, SHP-2 PTPase Inhibitor. …”
  4. 1404
  5. 1405
  6. 1406
  7. 1407
  8. 1408
  9. 1409
  10. 1410

    Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

    Published 2019
    “…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”
  11. 1411

    Inhibition of MRP1 significantly decreases basal and apoptotic GSH efflux. by Parameswaran G. Sreekumar (176748)

    Published 2012
    “…GSH release from MRP1-silenced ARPE-19 cells incubated with 150 µM H<sub>2</sub>O<sub>2</sub> for 5 h in serum free medium. A significant decrease (P<0.001 vs scrambled control) in GSH release was observed in 5 h. …”
  12. 1412
  13. 1413

    Nilotinib decreases the <i>in vitro</i> tumorigenicity of HEI-193 cells. by Nesrin Sabha (127278)

    Published 2013
    “…(C) The mean maximal colony diameter was decreased by nilotinib at ≥3 µM in PDGF-BB media, and at ≥5 µM in GM. …”
  14. 1414
  15. 1415
  16. 1416
  17. 1417
  18. 1418
  19. 1419

    The number of behavioral arrests in DKO mice decreased following systemic atropine. by Mike Kalogiannis (224818)

    Published 2011
    “…<p>(A) Mean (± SEM) time per mouse spent in full behavioral arrests are plotted in 30 min bins across the entire recording period following IP injections of saline (open symbols) and atropine (0.5 mg/kg; filled symbols). …”
  20. 1420